Insider · CIK 0001969365
Emily Pimblett
officer
Files at CLYM (Climb Bio, Inc.). First filing Dec 20, 2024, latest Jun 20, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $5,605 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLYM: Climb Bio, Inc.
CLYMOct 9, 2026 · close 11.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Climb Bio, Inc. | $1,540 1,242 shares | -6% | +7% from low-86% from high | |
| 0Weak | Climb Bio, Inc. | $1,571 1,199 shares | -7% | - | |
| 0Weak | Climb Bio, Inc. | $2,495 1,235 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | CLYM Climb Bio, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | - | - | 20,130 | Jun 20, 2025 |
| Jun 20, 2025 | CLYM Climb Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -1,242 | $1.24 | $1,540 | 18,888 | Jun 20, 2025 |
| Jun 18, 2025 | CLYM Climb Bio, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,000 | $0.00 | $0 | 15,000 | Jun 20, 2025 |
| Mar 18, 2025 | CLYM Climb Bio, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | - | - | 16,329 | Mar 20, 2025 |
| Mar 20, 2025 | CLYM Climb Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -1,199 | $1.31 | $1,571 | 15,130 | Mar 20, 2025 |
| Mar 18, 2025 | CLYM Climb Bio, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,000 | $0.00 | $0 | 20,000 | Mar 20, 2025 |
| Jan 13, 2025 | CLYM Climb Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jan 15, 2025 |
| Dec 18, 2024 | CLYM Climb Bio, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | - | - | 12,564 | Dec 20, 2024 |
| Dec 19, 2024 | CLYM Climb Bio, Inc. | SOpen-market sale Common Stock10b5-1 | -1,235 | $2.02 | $2,495 | 11,329 | Dec 20, 2024 |
| Dec 18, 2024 | CLYM Climb Bio, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,000 | $0.00 | $0 | 25,000 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.